HUP9901295A2 - Perfluor-alkil tartalmú fémkomplexek, eljárás előállításukra és az NMR-diagnosztikában való alkalmazásuk - Google Patents
Perfluor-alkil tartalmú fémkomplexek, eljárás előállításukra és az NMR-diagnosztikában való alkalmazásukInfo
- Publication number
- HUP9901295A2 HUP9901295A2 HU9901295A HUP9901295A HUP9901295A2 HU P9901295 A2 HUP9901295 A2 HU P9901295A2 HU 9901295 A HU9901295 A HU 9901295A HU P9901295 A HUP9901295 A HU P9901295A HU P9901295 A2 HUP9901295 A2 HU P9901295A2
- Authority
- HU
- Hungary
- Prior art keywords
- general formula
- formula
- pipe
- breaks
- hydrogen atom
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 125000005010 perfluoroalkyl group Chemical group 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 239000002184 metal Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 239000000843 powder Substances 0.000 abstract 2
- 238000005160 1H NMR spectroscopy Methods 0.000 abstract 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 239000002872 contrast media Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000000428 dust Substances 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 abstract 1
- 150000007529 inorganic bases Chemical class 0.000 abstract 1
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 abstract 1
- 239000011630 iodine Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229910021645 metal ion Inorganic materials 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 150000007530 organic bases Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000004611 spectroscopical analysis Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D25/00—Details of other kinds or types of rigid or semi-rigid containers
- B65D25/14—Linings or internal coatings
- B65D25/16—Loose, or loosely-attached, linings
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D47/00—Closures with filling and discharging, or with discharging, devices
- B65D47/04—Closures with discharging devices other than pumps
- B65D47/06—Closures with discharging devices other than pumps with pouring spouts or tubes; with discharge nozzles or passages
- B65D47/08—Closures with discharging devices other than pumps with pouring spouts or tubes; with discharge nozzles or passages having articulated or hinged closures
- B65D47/0804—Closures with discharging devices other than pumps with pouring spouts or tubes; with discharge nozzles or passages having articulated or hinged closures integrally formed with the base element provided with the spout or discharge passage
- B65D47/0833—Hinges without elastic bias
- B65D47/0847—Hinges without elastic bias located within a flat surface of the base element
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D83/00—Containers or packages with special means for dispensing contents
- B65D83/0055—Containers or packages provided with a flexible bag or a deformable membrane or diaphragm for expelling the contents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/76—Metal complexes of amino carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/10—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Mechanical Engineering (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A találmány tárgyát az (I) általánős képletű perflűőr-alkil-tartalmúvegyületek -, amely képletben RF jelentése perflűőrőzőtt, adőttesetben elágazó láncú -CnF2nX általánős képletű csőpőrt -, amelyképletben X jelentése láncvégi flűőr-, klór-, bróm-, jód- vagyhidrőgénatőm, és n értéke 4-től 30-ig terjedő egész szám, L jelentéseközvetlen kémiai kötés, metilén- vagy -NHCO- képletű vagyR1 -[(CH2)ű-NHCOCH2-(CH2)p]q-N-SO2 általánős képletű csőpőrt - amely képletben pértéke 0-tól 10-ig terjedő egész szám, q és ű jelentése egymástólfüggetlenül 0 vagy 1, R1 jelentése hidrőgénatőm, metil-, hidrőxi-metil- vagy karbőxi-metil-csőpőrt, vagy 2-15 szénatőmős alkillánc,amelyet különböző atőmők vagy atőmcsőpőrtők megszakíthatnak, éskülönböző csőpőrtőkkal szűbsztitűált lehet, vagy adőtt esetbenelágazó, adőtt esetben telítetlen 2-30 szénatőmős alkillánc, amelyetkülönböző atőmők vagy atőmcsőpőrtők megszakíthatnak, illetve különbözőcsőpőrtőkkal szűbsztitűált lehet; A jelentése egy kőmplexképző vagyfémkőmplexcsőpőrt vagy annak szerves és/vagy szervetlen bázisőkkal,vagy aminősavakkal, vagy aminősavamidőkkal alkőtőtt sói, éspedig a(II)-(XIII) általánős képletű csőpőrtők - amely képletekben R3, Z1 ésY egymástól függetlenek, és R3 jelentése azőnős az R1 jelentéséremegadőttakkal, vagy egy -(CH2)m-L-RF általánős képletű csőpőrt, Z1jelentése hidrőgénatőm vagy egy 21-29, 39, 42, 44 vagy 57-83 rendszámúfémiőn-ekvivalens, Y jelentése -OZ1, vagy (h) vagy (i) általánősképletű csőpőrt. A találmány tárgyát képezik a találmány szerintivegyületek előállítására szőlgáló eljárásők is. A találmány tárgyátképezik tővábbá a találmány szerinti vegyületeket tartalmazógyógyszerkészítmények is, amelyeket az 1H-NMR-diganősztikában és -spektrőszkópiában, illetve a röntgen- diagnősztikábankőntrasztanyagként, a radiődiagnősztikában és -terápiában pediggyógyszerként lehet alkalmazni.. ŕ
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19603033A DE19603033A1 (de) | 1996-01-19 | 1996-01-19 | Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik |
| PCT/EP1997/000209 WO1997026017A2 (de) | 1996-01-19 | 1997-01-16 | Perfluoralkylhaltige metallkomplexe und ihre verwendung in der nmr-diagnostik |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HUP9901295A2 true HUP9901295A2 (hu) | 1999-07-28 |
| HUP9901295A3 HUP9901295A3 (en) | 2004-05-28 |
| HU226199B1 HU226199B1 (en) | 2008-06-30 |
Family
ID=7783921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9901295A HU226199B1 (en) | 1996-01-19 | 1997-01-16 | Perfluoroalkyl-containing metal complexes, process for their preparation and their use in nmr diagnostics |
Country Status (28)
| Country | Link |
|---|---|
| US (3) | US6468502B1 (hu) |
| EP (1) | EP0874645B1 (hu) |
| JP (1) | JP2000506511A (hu) |
| KR (1) | KR100539041B1 (hu) |
| CN (1) | CN1203898C (hu) |
| AT (1) | ATE215386T1 (hu) |
| AU (1) | AU716788B2 (hu) |
| BG (1) | BG62914B1 (hu) |
| BR (1) | BR9707053B1 (hu) |
| CZ (1) | CZ298769B6 (hu) |
| DE (2) | DE19603033A1 (hu) |
| DK (1) | DK0874645T3 (hu) |
| EE (1) | EE04298B1 (hu) |
| ES (1) | ES2174215T3 (hu) |
| HK (1) | HK1018404A1 (hu) |
| HU (1) | HU226199B1 (hu) |
| IL (1) | IL125311A (hu) |
| IS (1) | IS2127B (hu) |
| NO (1) | NO319680B1 (hu) |
| NZ (1) | NZ330579A (hu) |
| PL (1) | PL187466B1 (hu) |
| PT (1) | PT874645E (hu) |
| RU (1) | RU2242477C2 (hu) |
| SK (1) | SK283576B6 (hu) |
| TW (1) | TW542841B (hu) |
| UA (1) | UA65533C2 (hu) |
| WO (1) | WO1997026017A2 (hu) |
| ZA (1) | ZA97419B (hu) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19603033A1 (de) * | 1996-01-19 | 1997-07-24 | Schering Ag | Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik |
| UA59384C2 (uk) * | 1996-12-20 | 2003-09-15 | Пфайзер, Інк. | Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі |
| DE19729013A1 (de) * | 1997-07-03 | 1999-02-04 | Schering Ag | Oligomere, perfluoralkylhaltige Verbindungen, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik |
| DE19744004C1 (de) * | 1997-09-26 | 1999-07-22 | Schering Ag | Lipophile Metall-Komplexe für Nekrose und Infarkt-Imaging |
| US6495118B1 (en) * | 1997-09-26 | 2002-12-17 | Schering Aktiengesellschaft | Lipophilic metal complexes for necrosis and infarction imaging |
| US6461587B1 (en) | 1999-03-22 | 2002-10-08 | Schering Aktiengesellschaft | Perfluoroalkylamides, their production and their use in diagnosis |
| DE19914101C1 (de) * | 1999-03-22 | 2000-10-12 | Schering Ag | Perfluoralkylamide, ihre Herstellung und ihre Verwendung in der Diagnostik |
| DE19948650A1 (de) * | 1999-09-29 | 2001-07-19 | Diagnostikforschung Inst | Galenische Formulierungen |
| DE19948651B4 (de) * | 1999-09-29 | 2006-10-05 | Schering Ag | Para- und diamagnetische perfluorhaltige Verbindungen enthaltende galenische Formulierungen, deren Herstellung und Verwendung |
| EP1088559A3 (de) * | 1999-09-29 | 2002-10-02 | INSTITUT FÜR DIAGNOSTIKFORSCHUNG GmbH AN DER FREIEN UNIVERSITÄT BERLIN | Galenische Formulierungen |
| US6676928B2 (en) | 2000-08-11 | 2004-01-13 | Schering Aktiengesellschaft | Perfluoroalkyl-containing complexes with polar radicals, process for their production and their use |
| DE10066210B4 (de) * | 2000-08-11 | 2008-02-28 | Bayer Schering Pharma Ag | Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Plaques |
| DE10040380B4 (de) * | 2000-08-11 | 2006-03-09 | Schering Ag | Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Plaques |
| US6818203B2 (en) * | 2000-08-11 | 2004-11-16 | Schering Aktiengesellschaft | Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of plaque, tumors and necroses |
| DE10040858C2 (de) * | 2000-08-11 | 2003-12-18 | Schering Ag | Perfluoralkylhaltige Komplexe mit polaren Resten, Verfahren zu deren Herstellung und ihre Verwendung |
| US6641797B2 (en) | 2000-08-11 | 2003-11-04 | Schering Aktiengesellschaft | Perfluoroalkyl-containing complexes with sugar radicals, process for their production and their use |
| DE10040381C1 (de) * | 2000-08-11 | 2002-06-06 | Schering Ag | Perfluoralkylhaltige Komplexe mit Zuckerresten, Verfahren zu deren Herstellung und ihre Verwendung |
| DE10135356C1 (de) | 2001-07-20 | 2003-04-17 | Schering Ag | Makrocyclische Metallkomplexe und deren Verwendung zur Herstellung von Konjugaten mit Biomolekülen |
| ES2260468T3 (es) * | 2001-08-03 | 2006-11-01 | Glaxo Group Limited | Compuestos tensioactivos y usos de los mismos. |
| NO20015814D0 (no) * | 2001-11-28 | 2001-11-28 | Amersham Health As | Metallkompleksforbindelser |
| US7344704B2 (en) | 2002-07-10 | 2008-03-18 | Schering Ag | Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of intravascular thrombi |
| AU2003249999A1 (en) * | 2002-07-10 | 2004-02-02 | Hans Robert Kalbitzer | 1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours |
| DE10231799B4 (de) * | 2002-07-10 | 2006-10-05 | Schering Ag | Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Intravasalen Thromben |
| EP2014728A1 (en) | 2005-01-13 | 2009-01-14 | Cinvention Ag | Composite material coatings |
| DE102005008309A1 (de) * | 2005-02-17 | 2006-08-24 | Schering Ag | Pharmazeutische Mittel enthaltend fluoralkylhaltige Metallkomplexe und Epothilone |
| DE102005033902B3 (de) * | 2005-07-15 | 2007-04-05 | Schering Ag | Perfluoralkylhaltige Komplexe, Verfahren zu deren Herstellung, sowie deren Verwendung und diese enthaltende pharmazeutische Mittel |
| DE102005033903B4 (de) * | 2005-07-15 | 2007-08-09 | Bayer Schering Pharma Ag | Perfluoralkylhaltige Komplexe, Verfahren zu deren Herstellung, sowie deren Verwendung und diese enthaltende pharmazeutische Mittel |
| DE102006021495A1 (de) * | 2006-05-09 | 2007-11-15 | Bayer Schering Pharma Ag | Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel zur Diagnose der Alzheimer Krankheit |
| BRPI0712326A2 (pt) * | 2006-06-09 | 2012-01-10 | Koninkl Philips Electronics Nv | método para a obtenção de informação relativa ao parámetro fìsico-quìmico através da formação de imagens mri depois da administração a um paciente de um agente de contraste, produto de programa de computador, dispositivo de armazenagem dos dados legìveis por máquina, sistema para formação de imagem mri para uso com agente de contraste, agente de contraste, e, preparação |
| DE102006049821A1 (de) | 2006-10-18 | 2008-04-24 | Bayer Schering Pharma Aktiengesellschaft | Metallchelate mit perfluoriertem PEG-Rest, Verfahren zu deren Herstellung, sowie deren Verwendung |
| GB0708411D0 (en) * | 2007-05-01 | 2007-06-06 | Univ Durham | Lanthanide probes |
| US20110217241A1 (en) * | 2008-11-14 | 2011-09-08 | University Of Maryland, Baltimore | Conjugates of 19f mr imaging tracers for use in multi-chromic mri imaging |
| CN107001918A (zh) * | 2014-12-08 | 2017-08-01 | 3M创新有限公司 | 氢氟烯烃及其使用方法 |
| EP3101012A1 (en) | 2015-06-04 | 2016-12-07 | Bayer Pharma Aktiengesellschaft | New gadolinium chelate compounds for use in magnetic resonance imaging |
| US10835623B2 (en) | 2015-08-13 | 2020-11-17 | The General Hospital Corporation | Manganese-based chelate conjugates for molecular MR imaging |
| WO2018096082A1 (en) | 2016-11-28 | 2018-05-31 | Bayer Pharma Aktiengesellschaft | High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging |
| CA3120665A1 (en) | 2018-11-23 | 2020-05-28 | Bayer Aktiengesellschaft | Formulation of contrast media and process of preparation thereof |
| US20200397924A1 (en) * | 2019-01-28 | 2020-12-24 | Hubei Tianshu Pharmaceutical Co., Ltd | Preparation method of intermediate of gadolinium-based ionic contrast agent and use thereof |
| CN110922365B (zh) * | 2019-12-13 | 2021-04-27 | 山东铂源药业有限公司 | 一种高纯度轮环藤宁的制备方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4859584A (en) | 1986-10-31 | 1989-08-22 | Smithkline Beckman Corporation | Cell growth rate determination by measurement of changes in cyanine dye levels in plasma membranes |
| US4762701A (en) | 1986-10-31 | 1988-08-09 | Smithkline Beckman Corporation | In vivo cellular tracking |
| US5672334A (en) | 1991-01-16 | 1997-09-30 | Access Pharmaceuticals, Inc. | Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans |
| US5114703A (en) * | 1989-05-30 | 1992-05-19 | Alliance Pharmaceutical Corp. | Percutaneous lymphography using particulate fluorocarbon emulsions |
| DE3930674A1 (de) | 1989-09-11 | 1991-03-21 | Diagnostikforschung Inst | Bifunktionelle chelatbildner zur komplexierung von tc- und re-isotopen, verfahren zu ihrer herstellung und darstellung von konjugaten daraus sowie deren verwendung in diagnostik und therapie |
| US5248498A (en) * | 1991-08-19 | 1993-09-28 | Mallinckrodt Medical, Inc. | Fullerene compositions for magnetic resonance spectroscopy and imaging |
| JPH06181890A (ja) * | 1992-10-06 | 1994-07-05 | Terumo Corp | Ｍｒｉ造影剤 |
| US5401493A (en) * | 1993-03-26 | 1995-03-28 | Molecular Biosystems, Inc. | Perfluoro-1H,-1H-neopentyl containing contrast agents and method to use same |
| DE4317588C2 (de) | 1993-05-24 | 1998-04-16 | Schering Ag | Fluorhaltige makrocyclische Metallkomplexe, Verfahren zu ihrer Herstellung, sowie ihre Verwendung |
| JPH0797340A (ja) | 1993-06-03 | 1995-04-11 | Terumo Corp | Ｍｒｉ造影剤組成物 |
| DE19603033A1 (de) * | 1996-01-19 | 1997-07-24 | Schering Ag | Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik |
| US6019959A (en) * | 1997-07-31 | 2000-02-01 | Schering Aktiengesellschaft | Oligomeric compounds that contain perfluoroalkyl, process for their production, and their use in NMR diagnosis |
| US6461587B1 (en) * | 1999-03-22 | 2002-10-08 | Schering Aktiengesellschaft | Perfluoroalkylamides, their production and their use in diagnosis |
| EP1088559A3 (de) * | 1999-09-29 | 2002-10-02 | INSTITUT FÜR DIAGNOSTIKFORSCHUNG GmbH AN DER FREIEN UNIVERSITÄT BERLIN | Galenische Formulierungen |
| US6676928B2 (en) * | 2000-08-11 | 2004-01-13 | Schering Aktiengesellschaft | Perfluoroalkyl-containing complexes with polar radicals, process for their production and their use |
| US6818203B2 (en) * | 2000-08-11 | 2004-11-16 | Schering Aktiengesellschaft | Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of plaque, tumors and necroses |
| US6641797B2 (en) * | 2000-08-11 | 2003-11-04 | Schering Aktiengesellschaft | Perfluoroalkyl-containing complexes with sugar radicals, process for their production and their use |
-
1996
- 1996-01-19 DE DE19603033A patent/DE19603033A1/de not_active Withdrawn
-
1997
- 1997-01-16 HU HU9901295A patent/HU226199B1/hu not_active IP Right Cessation
- 1997-01-16 PT PT97902179T patent/PT874645E/pt unknown
- 1997-01-16 UA UA98084472A patent/UA65533C2/uk unknown
- 1997-01-16 NZ NZ330579A patent/NZ330579A/xx unknown
- 1997-01-16 RU RU98115579/04A patent/RU2242477C2/ru not_active IP Right Cessation
- 1997-01-16 PL PL97327931A patent/PL187466B1/pl not_active IP Right Cessation
- 1997-01-16 AT AT97902179T patent/ATE215386T1/de not_active IP Right Cessation
- 1997-01-16 DE DE59706863T patent/DE59706863D1/de not_active Expired - Fee Related
- 1997-01-16 IL IL12531197A patent/IL125311A/en not_active IP Right Cessation
- 1997-01-16 EE EE9800204A patent/EE04298B1/xx not_active IP Right Cessation
- 1997-01-16 DK DK97902179T patent/DK0874645T3/da active
- 1997-01-16 JP JP9525698A patent/JP2000506511A/ja not_active Ceased
- 1997-01-16 EP EP97902179A patent/EP0874645B1/de not_active Expired - Lifetime
- 1997-01-16 SK SK990-98A patent/SK283576B6/sk unknown
- 1997-01-16 CN CNB971917701A patent/CN1203898C/zh not_active Expired - Fee Related
- 1997-01-16 WO PCT/EP1997/000209 patent/WO1997026017A2/de active IP Right Grant
- 1997-01-16 ES ES97902179T patent/ES2174215T3/es not_active Expired - Lifetime
- 1997-01-16 BR BRPI9707053-0A patent/BR9707053B1/pt not_active IP Right Cessation
- 1997-01-16 KR KR1019980705523A patent/KR100539041B1/ko not_active IP Right Cessation
- 1997-01-16 CZ CZ0226398A patent/CZ298769B6/cs not_active IP Right Cessation
- 1997-01-16 AU AU15977/97A patent/AU716788B2/en not_active Ceased
- 1997-01-17 ZA ZA9700419A patent/ZA97419B/xx unknown
- 1997-01-18 TW TW086100514A patent/TW542841B/zh not_active IP Right Cessation
-
1998
- 1998-06-30 IS IS4790A patent/IS2127B/xx unknown
- 1998-07-15 BG BG102632A patent/BG62914B1/bg unknown
- 1998-07-16 NO NO19983287A patent/NO319680B1/no unknown
-
1999
- 1999-08-13 HK HK99103506A patent/HK1018404A1/xx not_active IP Right Cessation
- 1999-11-08 US US09/435,918 patent/US6468502B1/en not_active Expired - Fee Related
-
2002
- 2002-07-18 US US10/197,421 patent/US6916461B2/en not_active Expired - Fee Related
-
2004
- 2004-10-05 US US10/957,628 patent/US7226578B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9901295A2 (hu) | Perfluor-alkil tartalmú fémkomplexek, eljárás előállításukra és az NMR-diagnosztikában való alkalmazásuk | |
| HUP0202017A2 (hu) | Új vegyületek | |
| JPH07242615A (ja) | エーテル置換イソニトリルおよびその製法 | |
| NO305515B1 (no) | 5-amino-8-metyl-7-pyrrolidinylkinolin-3-karboksylsyrederivater og farmas°ytiske preparater inneholdende disse | |
| HUP9901387A2 (hu) | Disztamicinszármazékok, eljárás előállításukra és tumorellenes és vírusellenes szerként történő alkalmazásuk | |
| JPH06502640A (ja) | テクネチウム−９９ｍ錯化合物の放射性医薬としての使用 | |
| ES8504797A1 (es) | Procedimiento para la preparacion de nuevos derivados de hidroxiimino-octahidro-indolo(2,3-a)quinolizina | |
| Benati et al. | Reactivity of an (arylthio) thiocarbonyl radical. Intramolecular addition to the azido group | |
| Rozen et al. | A new approach toward the synthesis and chemistry of fluoroxy compounds | |
| BG104971A (en) | Platinum complex, its preparation and therapeutic application | |
| Bly et al. | Alkyl migration in an iron (II) alkylidene: a new route to a stabilized bridgehead olefin | |
| HUP0003880A2 (hu) | Biciklusos heteroaril-hidroxaminsavak orto-szulfonamido-származékai, ezeket tartalmazó mátrix-metalloproteináz- és TACE-inhibitorként hatásos gyógyszerkészítmény és eljárás előállításukra | |
| CA1230342A (en) | Tc99m-phenida, radioscintigraphic agent for diagnosis of hepatobiliary disease | |
| Greco et al. | Novel thrombin inhibitors that are based on a macrocyclic tripeptide motif | |
| Banks et al. | Oxidative coupling of optically active vinylcopper reagents. Stereospecific generation of a novel dissymmetric conjugated diene | |
| HUP0001180A2 (hu) | Új eritromicinszármazékok, eljárás előállításukra és gyógyszerként történő alkalmazásuk | |
| HUP9801951A2 (hu) | Új diszubsztituált transz-3,4,4,4a,5,6,10b-hexahidro-2H-naft-[1,2-b] [1,4]-oxazin-származékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyászati készítmények | |
| JPH023619A (ja) | ２つの芳香環を含む化合物のジアシル化方法 | |
| ES8304571A1 (es) | "procedimiento para la preparacion de nuevas 1,4,9,10-tetrahidro-pirazolo (4,3-e)pirido (3,2-b) (1,4)diazepin-10-onas". | |
| Andersen | Trimethylbis [bis (trimethylsilyl) amido] tantalum (V) and [(trimethylsilyl) methyl][trimethylsily) methylidene] bis [bis (trimethylsilyl) amido] tantalum (V | |
| WO1990002571A1 (fr) | Produits radiopharmaceutiques constitues par des complexes tetraphosphonates | |
| HUP0004543A2 (hu) | Aminopirrolin vegyületek, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyszerkészítmények | |
| HUP9901070A2 (hu) | Eljárás 1-(3-trialkil-szilil-fenil)-2,2,2-trifluor-metil-etanon-származékok előállítására | |
| ES8302702A1 (es) | Procedimiento para la produccion de nuevos compuestos de lactama. | |
| IT9021306A1 (it) | Addotti con acido boronico di complessi di tecnezio 99m -immino- diossima |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of definitive patent protection due to non-payment of fees |